The place of goal-directed haemodynamic therapy in the 21st century

BJA Education, 16 (8): 286 (2016) doi: 10.1093/bjaed/mkw045

Matrix reference

The place of goal-directed haemodynamic therapy in the 21st century BJA Education, 2016, 16(6): 179–185, DOI 10.1093/bjaed/mkv039 In the originally published version, the Declaration of interest section was incomplete. It should have read:

Declaration of interest M.P.G. has received unrestricted grant funding from Deltex Medical Ltd paid to his institution (UoS/UHS/UCL/UCLH) and fees for lecturing from Fresenius Kabi (2008) and Edwards Lifesciences (2009 and 2016). M.G.M. is Smiths Medical Professor of Anaesthesia and Critical Care UCL and a Consultant at UCLH. He is Director of the UCL Centre for Anaesthesia and The UCL Discovery Lab and a resident PI at the Institute of Spots Exercise and Health. He is a paid Consultant for Edwards Lifesciences (via UCL Consulting and independently) and Deltex in the USA. He was a National Clinical Advisor for the Department of Health Enhanced Recovery Partnership until May 2013; Stock holder and advisory board for Medical Defence Technologies LLC (3Gastrostim2 patented);

Director Bloomsbury Innovation Group a community interest company owned by UCLH Charity; Co-Inventor of 3QUENCH 2 (fluid management system) IP being exploited by UCL Business. His institution has also received charitable donations and grants from Smiths Medical Endowment, Deltex Medical and Fresenius-kabi. He was also co-author of the GIFTASUP guidelines on peri-operative fluid management; Editor in Chief of Peri-operative Medicine; on the Editorial Board of the BJA and Critical Care; a member of the Improving Surgical Outcomes Group; Expert advisor to the NICE IV fluids guideline development group; Chairman of the Board of The National Institute of Academic Anaesthesia; Co-Director Xtreme Everest; CoChair Evidence Based Perioperative Medicine (EBPOM). In the past 20 years he has also received honoraria and travel expenses from Fresenius-kabi, BBraun, Baxter, Cheetah, LidCo, AQIX, Hospira and Massimo. He does a small amount of Private Medical Practice. J.-O.C.D. has no conflicts of interest to declare.

© The Author 2016. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: [email protected]

286

Downloaded from https://academic.oup.com/bjaed/article-abstract/16/8/286/2364855 by guest on 23 March 2019

Corrigendum